BETOPTIC Drug Patent Profile
✉ Email this page to a colleague
When do Betoptic patents expire, and what generic alternatives are available?
Betoptic is a drug marketed by Sandoz, Alcon, and Novartis. and is included in three NDAs.
The generic ingredient in BETOPTIC is betaxolol hydrochloride; pilocarpine hydrochloride. There are eleven drug master file entries for this compound. Additional details are available on the betaxolol hydrochloride; pilocarpine hydrochloride profile page.
Summary for BETOPTIC
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 210 |
Clinical Trials: | 1 |
Patent Applications: | 4,284 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BETOPTIC |
DailyMed Link: | BETOPTIC at DailyMed |
Recent Clinical Trials for BETOPTIC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alcon Research | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for BETOPTIC
US Patents and Regulatory Information for BETOPTIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Alcon | BETOPTIC PILO | betaxolol hydrochloride; pilocarpine hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 020619-001 | Apr 17, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | BETOPTIC S | betaxolol hydrochloride | SUSPENSION/DROPS;OPHTHALMIC | 019845-001 | Dec 29, 1989 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BETOPTIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | BETOPTIC | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019270-001 | Aug 30, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BETOPTIC
See the table below for patents covering BETOPTIC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Greece | 61363 | PREPARATION PROCESS OF ETHERS OF SUBSTITUTED PHENOLS | ⤷ Try a Trial |
Finland | 763132 | ⤷ Try a Trial | |
Australia | 501581 | ⤷ Try a Trial | |
Netherlands | 7612123 | ⤷ Try a Trial | |
Australia | 1925976 | ⤷ Try a Trial | |
Japan | S5848543 | ⤷ Try a Trial | |
Belgium | 847801 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |